• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Tolerance of acellular pertussis vaccine booster injection in 15-20-month-old children].

作者信息

Mallet E, Puyt A, Arson S, Surbled V

机构信息

Département de pédiatrie, Hôpital Charles-Nicolle, Rouen, France.

出版信息

Arch Pediatr. 2000 Apr;7(4):410-4. doi: 10.1016/S0929-693X(00)88839-9.

DOI:10.1016/S0929-693X(00)88839-9
PMID:10793931
Abstract

Severe reactions to whole cell pertussis vaccine are the main reason for the poor adhesion of parents and practitioners to pertussis vaccine booster injections in children, leading to a poor immunization in the population, particularly in young adults. The acellular pertussis vaccine appears to be better tolerated while keeping a good immunogenicity. In a randomized multicentric study on pertussis vaccine booster injection tolerance in 386 15-20 month-old children, we confirmed the better local and general tolerance of the acellular vaccine as compared with the whole cell vaccine. This should help to develop a positive opinion toward pertussis vaccine among parents and practitioners, and to improve the level of active pertussis immunization among children, adolescents, and young adults.

摘要

相似文献

1
[Tolerance of acellular pertussis vaccine booster injection in 15-20-month-old children].
Arch Pediatr. 2000 Apr;7(4):410-4. doi: 10.1016/S0929-693X(00)88839-9.
2
Adverse reactions and serologic response to a booster dose of acellular pertussis vaccine in children immunized with acellular or whole-cell vaccine as infants.
Pediatrics. 1989 Jul;84(1):62-7.
3
Pertussis in adults: possible use of booster doses for control.成人百日咳:加强剂量用于控制的可能性。
Tokai J Exp Clin Med. 1988;13 Suppl:125-8.
4
[Pertussis vaccination with acellular vaccines. Tolerance--effectiveness--current vaccination recommendations].[使用无细胞疫苗进行百日咳疫苗接种。耐受性——有效性——当前的疫苗接种建议]
Fortschr Med. 1997 Aug 30;115(24):22-7.
5
[Acellular pertussis vaccine (Pa)].无细胞百日咳疫苗(Pa)
Przegl Epidemiol. 1995;49(3):325-9.
6
Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.联合低抗原含量白喉-破伤风-无细胞百日咳和脊髓灰质炎疫苗(dTpa-IPV)用于成人加强免疫接种。
Vaccine. 2005 May 25;23(28):3657-67. doi: 10.1016/j.vaccine.2005.02.013.
7
[Acellular anti-pertussis vaccine].[无细胞抗百日咳疫苗]
Bull Soc Pathol Exot. 1991;84(5 Pt 5):859-65.
8
Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age.对瑞典在3、5和12月龄接种无细胞百日咳疫苗的儿童进行长期随访表明,5至7岁时需要加强一剂疫苗。
Pediatrics. 2006 Sep;118(3):978-84. doi: 10.1542/peds.2005-2746.
9
The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in Canada.从全细胞百日咳疫苗转换为无细胞百日咳疫苗对加拿大百日咳住院儿童流行病学的影响。
Pediatr Infect Dis J. 2007 Jan;26(1):31-5. doi: 10.1097/01.inf.0000247055.81541.04.
10
Cellular and acellular pertussis vaccines in adults.成人用细胞型和无细胞型百日咳疫苗
Clin Infect Dis. 1999 Jun;28 Suppl 2:S118-23. doi: 10.1086/515064.